BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23300530)

  • 21. Knockdown of Ezrin by RNA interference reverses malignant behavior of human pancreatic cancer cells in vitro.
    Zhong ZQ; Song MM; He Y; Cheng S; Yuan HS
    Asian Pac J Cancer Prev; 2012; 13(8):3781-9. PubMed ID: 23098471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition.
    Zhao R; Gong L; Li L; Guo L; Zhu D; Wu Z; Zhou Q
    Exp Cell Res; 2013 Mar; 319(5):740-9. PubMed ID: 23137649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway.
    Li W; Ma J; Ma Q; Li B; Han L; Liu J; Xu Q; Duan W; Yu S; Wang F; Wu E
    Curr Med Chem; 2013; 20(33):4185-4194. PubMed ID: 23992306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential function of oxymatrine as a novel suppressor of epithelial-to-mesenchymal transition in lung tumor cells.
    Jung YY; Baek SH; Narula AS; Namjoshi OA; Blough BE; Ahn KS
    Life Sci; 2021 Nov; 284():119893. PubMed ID: 34454947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta1 in cultured rat hepatic stellate cells.
    Liu X; Wang W; Hu H; Tang N; Zhang C; Liang W; Wang M
    Pharm Res; 2006 Jan; 23(1):82-9. PubMed ID: 16341574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer.
    Paik WH; Ryu JK; Jeong KS; Park JM; Song BJ; Lee SH; Kim YT; Yoon YB
    World J Gastroenterol; 2014 Jul; 20(26):8545-57. PubMed ID: 25024609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3.
    Zhu L; Qin H; Li PY; Xu SN; Pang HF; Zhao HZ; Li DM; Zhao Q
    J Exp Clin Cancer Res; 2012 Mar; 31(1):29. PubMed ID: 22458379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-β1/Smad signaling pathway.
    Wang X; Liu C; Wang J; Fan Y; Wang Z; Wang Y
    Oncol Rep; 2017 Feb; 37(2):747-753. PubMed ID: 27959430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells.
    Zhang LL; Jiang XM; Huang MY; Feng ZL; Chen X; Wang Y; Li H; Li A; Lin LG; Lu JJ
    Phytomedicine; 2019 Jan; 52():32-39. PubMed ID: 30599910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer.
    Yamada D; Kobayashi S; Wada H; Kawamoto K; Marubashi S; Eguchi H; Ishii H; Nagano H; Doki Y; Mori M
    Eur J Cancer; 2013 May; 49(7):1725-40. PubMed ID: 23298711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer.
    Wu Y; Sato F; Yamada T; Bhawal UK; Kawamoto T; Fujimoto K; Noshiro M; Seino H; Morohashi S; Hakamada K; Abiko Y; Kato Y; Kijima H
    Int J Oncol; 2012 Oct; 41(4):1337-46. PubMed ID: 22825629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia.
    Ni J; Zhou S; Yuan W; Cen F; Yan Q
    J Recept Signal Transduct Res; 2019; 39(5-6):399-406. PubMed ID: 31875764
    [No Abstract]   [Full Text] [Related]  

  • 34. Cooperative involvement of NFAT and SnoN mediates transforming growth factor-β (TGF-β) induced EMT in metastatic breast cancer (MDA-MB 231) cells.
    Sengupta S; Jana S; Biswas S; Mandal PK; Bhattacharyya A
    Clin Exp Metastasis; 2013 Dec; 30(8):1019-31. PubMed ID: 23832742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro.
    Xu J; Liu S; Yang X; Cao S; Zhou Y
    Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
    Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transition, invasion and metastasis of pancreatic cancer cells.
    Yu H; Song H; Xiao J; Chen H; Jin X; Lin X; Pan B; Ji W
    Biomed Pharmacother; 2017 Dec; 96():650-658. PubMed ID: 29035831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
    Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
    Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.
    Melisi D; Ishiyama S; Sclabas GM; Fleming JB; Xia Q; Tortora G; Abbruzzese JL; Chiao PJ
    Mol Cancer Ther; 2008 Apr; 7(4):829-40. PubMed ID: 18413796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.